CLINICAL_TRIALS
trial_result
· 2013-07-16
Clinical Trial Update: MDRS for Prevention of Nocturnal Hypoglycemia [Phase 1]
Summary
A Phase 1 study of MDRS for preventing nocturnal hypoglycemia in individuals with Type 1 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rabin Medical Center | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED